Class Action Lawsuit Filed Against Chemours Company Over Alleged Misleading Statements Regarding Opteon Demand
Pomerantz LLP has filed a class action lawsuit against The Chemours Company (NYSE: CC) and certain officers in the U.S. District Court for the District of Delaware. The suit alleges that the company made materially false and misleading statements regarding its business operations and prospects between February 20, 2026, and August 4, 2026. The complaint specifically claims that Chemours overstated aftermarket demand for its Opteon refrigeration products and failed to disclose that previous overselling had created an oversupplied channel. This lack of transparency allegedly rendered the company's 2026 financial guidance unreliable. Following a downward revision in adjusted EBITDA guidance and management's admission regarding inventory issues, Chemours' stock price dropped by 18.63% on August 5, 2026.